Labshake search
Citations for R&D Systems :
1 - 50 of 231 citations for Corning Hygromycin B Solution since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2021Quote: ... 1x Energy regeneration solution (#B-10 R&D systems), 75 mM ubiquitin (#U-100H R&D systems ...
-
bioRxiv - Microbiology 2020Quote: ... 50 µL of each solution A and B (R&D Systems) was added into each well ...
-
bioRxiv - Neuroscience 2022Quote: ... 100µL of collagen type I solution (Corning or R&D systems, 3 mg/mL with a pH adjusted to 7.0-7.2 with NaOH ...
-
bioRxiv - Molecular Biology 2023Quote: ... were prepared to obtain solutions of TGF-β1 (10 ng/mL and 25 ng/mL, R&D Systems 240-B-002), palmitic acid (PA ...
-
bioRxiv - Cancer Biology 2023Quote: ... and for granzyme B using human Granzyme B DuoSet ELISA (R&D Systems). All ELISAs were performed as per manufacturer’s instructions ...
-
bioRxiv - Microbiology 2023Quote: ... Cathepsin B (R&D Systems), soluble TMPRSS2 (Abnova) ...
-
bioRxiv - Neuroscience 2024Quote: ... and Cathepsin B 1:500 (goat anti-Cathepsin B, R&D Systems Cat# AF965, RRID:AB_2086949) in primary antibody buffer (PBS-T + 10% donkey serum) ...
-
bioRxiv - Immunology 2022Quote: ... and then treated with 10 ng/mL of recombinant human TGF-b (R&D Systems; 240-B-002) or 10 ng/mL of recombinant human IL-1β (R&D Systems ...
-
bioRxiv - Cell Biology 2024Quote: ... were cultured in B cell Excellerate medium with the CEllXVivo B cell expansion kit (R&D systems, UK). CD8+ T-cells (Cambridge Bioscience ...
-
bioRxiv - Immunology 2024Quote: ELISA targeting Granzyme B were conducted using the Human Granzyme B DuoSet ELISA (R&D Systems, Minnesota, USA). The procedure was done according to the manufacturer’s protocol with slight alterations for the Human Granzyme B DuoSet ELISA ELISA Assay Diluent (5X ...
-
bioRxiv - Molecular Biology 2021Quote: ... Mg-ATP (R&D systems B-20) and 10x E3 Ligase Reaction Buffer (R&D systems B-71) ...
-
bioRxiv - Systems Biology 2022Quote: ... TGFB1 (R&D systems, 240-B-002) was reconstituted at 100ug/mL in a 4mM hydrochloric acid ...
-
bioRxiv - Cancer Biology 2023Quote: ... and granzyme B ELISA (R&D Systems) after 48 hours of incubation at 37°C ...
-
Biosynthetic characterization and combinatorial biocatalysis of the cysteine protease inhibitor E-64bioRxiv - Biochemistry 2024Quote: ... Recombinant human procathepsin B (R&D systems) was activated to mature cathepsin B by incubation at 37 °C for 20 min in activation buffer (20 mM Na-acetate pH 5.5 ...
-
bioRxiv - Developmental Biology 2021Quote: Clones resistant to both hygromycin and geneticin were stimulated with mouse BMP9 (R&D Systems #5566-BP-101) or mouse BMP4 (R&D Systems #5020-BP-010 ...
-
bioRxiv - Microbiology 2023Quote: ... granzyme B (R&D Systems, Minneapolis, MN, USA), and perforin (abcam ...
-
bioRxiv - Cancer Biology 2023Quote: Recombinant human TGFβ1 (240-B R&D Systems) was stocked as 20 μg/ml in DMSO and AZ3146 (SML-1427 Sigma Aldrich ...
-
bioRxiv - Cell Biology 2023Quote: ... rhTGF-β1 ligand (R&D Systems; 240-B) was added to the plates at a final well concentration of 2ng/mL for 0 and 30 min ...
-
bioRxiv - Bioengineering 2024Quote: ... 50 ng/mL BMP4 (B; R&D systems), 50 μg/mL Vitamin C (V ...
-
bioRxiv - Developmental Biology 2020Quote: ... 0.2 ng/mL TGFβ (R&D systems 240-B), or 1 ng/mL PTH aa1-34 (R&D systems 3011/1 ...
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml TGFβ (R&D Systems #240-B) + 10 ng/ml EGF.
-
bioRxiv - Immunology 2021Quote: ... MICA/B-Alexa Fluor 700 (159207) (R&D Systems); anti-mouse CD3e-PerCP (145-2C11) ...
-
bioRxiv - Immunology 2020Quote: ... b) canine IL-4 (R&D Systems, Minneapolis, USA) at 125 ...
-
bioRxiv - Molecular Biology 2022Quote: ... 5ng/ml TGFβ (R&D systems, 240-B-002) was given ...
-
bioRxiv - Cell Biology 2024Quote: ... TGFβ1 (#240-B) was purchased from R&D Systems. For removing cell adhesion and passaging ...
-
bioRxiv - Immunology 2024Quote: ... and the adherent irradiated 40LB cells were co-cultured with 5 × 104 naïve splenic B cells in 6 mL of B cell media containing IL-4 (R&D Systems, 1 ng/mL) for 96 hours ...
-
bioRxiv - Cell Biology 2020Quote: ... and 10 ng/mL TGFβ (240-B, R&D Systems). To induce mature LCs ...
-
bioRxiv - Neuroscience 2022Quote: ... goat anti-Cathepsin B (1:1000, R&D systems AF965), rabbit anti-P2X4 (1:200 ...
-
bioRxiv - Biophysics 2022Quote: Human Apolipoprotein B Quantikine ELISA Kit (R&D Systems, DAPB00) was used according to manufacturer’s instructions ...
-
bioRxiv - Systems Biology 2022Quote: ... and TGFβ1 (10 ng/ml, R&D Systems #240-B) + EGF (10 ng/ml) ...
-
bioRxiv - Cell Biology 2023Quote: ... recombinant human BMP4 (10 ng/ml; “B”; R&D Systems), and 100 nM retinoic acid (“Ra” ...
-
bioRxiv - Cell Biology 2024Quote: ... 0.5 ng/mL TGFβ1 (R&D Systems; 240-B-002). Fresh ITS media was added on top after 4-5 days in culture ...
-
bioRxiv - Immunology 2024Quote: ... Granzyme B (both DuoSet ELISA kits from R&D systems), IL-6(12 ...
-
bioRxiv - Immunology 2024Quote: ... 1 × 105 B cells were added to each well in 6 mL of B cell media containing either IL-4 (R&D Systems, 1 ng/mL) or IL-21 (R&D Systems ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with 30 μM Latrunculin B (R&D Systems) dissolved in 0.1% DMSO at 30°C for 1 hour ...
-
bioRxiv - Molecular Biology 2021Quote: ... and 10x E3 Ligase Reaction Buffer (R&D systems B-71). Addition of Rik1-TAP complex purified from S ...
-
bioRxiv - Immunology 2020Quote: ... or 100 U/mL human recombinant Ifn-b (R&D systems). Cells were harvested 18 hrs post-transfection ...
-
bioRxiv - Immunology 2020Quote: ... or 100 U/mL human recombinant Ifn-b (R&D systems) at the cell counts and conditions previously described for the cellular luciferase assays ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 100ng/mL TGFB1 (R&D Systems, Cat#240-B-002) in 3F media for 3 days ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 100ng/mL TGFβ1 (R&D Systems, Cat#240-B-002) in 3F media for 3 days ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 ng/ml TGF-β1 (240-B-010, R&D Systems) or 10ng/ml Sema3A (1250-S3-025,R&D Systems) ...
-
bioRxiv - Immunology 2020Quote: ... Granzyme B was activated using Cathepsin C/DPPI (R&D Systems) according to manufacturer instructions ...
-
bioRxiv - Genomics 2024Quote: ... TGF-β1-induced (10 ng/mL) (R&D systems, #240-B) SSc fibroblasts were treated with 20 μM Ro5-3335 (TOCRIS ...
-
bioRxiv - Developmental Biology 2023Quote: ... 100 ng/mL rhTGFβ1 (R&D Systems Cat#240-B-002), 100 ng/mL rhNOGGIN (produced in-house ...
-
bioRxiv - Molecular Biology 2024Quote: ... TGF-β1 (240-B-002) was purchased from R&D Systems. Cells were lysed ...
-
Tuning trophoblast invasion in a gelatin hydrogel via soluble cues from the maternal-fetal interfacebioRxiv - Bioengineering 2020Quote: ... Recombinant human transforming growth factor β1 (TGFβ1; R&D Systems, 240-B) and recombinant human epidermal growth factor (EGF ...
-
bioRxiv - Microbiology 2021Quote: ... goat polyclonal anti-cathepsin B (R&D Systems AF953; 1:800 dilution), goat polyclonal anti-cathepsin D (R&D Systems AF1014 ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant cathepsin B and cathepsin L were purchased from R&D Systems.
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was purchased from R&D systems.
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was from R&D Systems (UK) and used at a final concentration of 0.5 ng/ml ...